The pharmaceutical landscape is experiencing a development with the emergence of GLP-1 transdermal systems . These exciting formulations offer a potential alternative to delivering glucagon-like peptide-1 https://woodyoaom259471.jaiblogs.com/68002719/glp-1-patches-a-new-way-to-control-blood-sugar